Virion Biotherapeutics

About:

Virion Biotherapeutics is a developer of biological antivirals creates to offer improved therapeutics for respiratory viral infections.

Website: https://www.virionbiotx.com/

Twitter/X: virionbio

Top Investors: DARPA, Abingworth

Description:

Virion’s mission is a developer of biological antivirals creates to offer improved therapeutics for respiratory viral infections. The company's antivirals focus on prevention and treatment of influenza and respiratory syncytial virus (RSV), enabling doctors to get a broad-spectrum therapy for respiratory viral infections, potentially simplifying and accelerating treatment by removing the need for differential diagnosis.

Total Funding Amount:

$21.2M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Zürich, Zurich, Switzerland

Founded Date:

2017-01-01

Contact Email:

contact(AT)virionbiotx.com

Founders:

Vanessa King

Number of Employees:

1-10

Last Funding Date:

2018-01-01

IPO Status:

Private

Industries:

© 2025 bioDAO.ai